Your browser doesn't support javascript.
loading
WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma.
Qin, Yong; Wang, Chao-Jun; Ye, Hai-Lin; Ye, Guan-Xiong; Wang, Shi; Pan, De-Biao; Wang, Jun; Shen, He-Juan; Xu, Sheng-Qian.
Afiliación
  • Qin Y; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Wang CJ; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Ye HL; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Ye GX; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Wang S; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Pan DB; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Wang J; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Shen HJ; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
  • Xu SQ; Department of Hepatobiliary Surgery, People Hospital of LiShui, The Sixth Affiliated Hospital of Wenzhou Medical University, The First Affiliated Hospital of LiShui University, Lishui, China.
Cell Biol Int ; 46(10): 1682-1692, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35880837
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Ubiquitina-Proteína Ligasas / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Cell Biol Int Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Ubiquitina-Proteína Ligasas / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Cell Biol Int Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido